Table 1.
Cost | Cost (95% CrI) | References |
---|---|---|
Treatment | ||
Cost per clinical case under five | $5.36 ($2.34, $13.51) | – |
Cost per clinical case over five | $6.26 ($3.24, $14.41) | – |
Cost per severe case under five | $31.03 ($5.40, $233.78) | – |
Cost per severe case over five | $33.93 ($8.30, $236.86) | – |
Treatment component costs | ||
RDT | $0.60 | [2] |
ACT under five | $0.30 | [23] |
ACT over five | $1.20 | [23] |
Injectable artesunate under five | $1.30 | [23] |
Injectable artesunate over five | $4.20 | [23] |
Outpatient visit | $2.61 ($0.61, $11.68) | [24] |
Inpatient day stay | $9.91 ($1.37, $77.50) | [24] |
Severe malaria hospital stay length | 3 days | [2] |
NMF per malaria fever | 1.86 (0.47, 7.12) | [25] |
Health system fixed cost (per capita) | 0.20 | [26] |
Treatment distribution per case (at 50% coverage) | $0.64 ($0.48, $3.01) | [2] |
LLINs | ||
LLIN cost per net | $2.24 | [27] |
LLIN in-country delivery cost per net delivered | $2.65 ($0.71, $4.61) | [9] |
LLIN programme fixed cost per capita per year | $0.20 | [26] |
SMC | ||
SMC cost per dose SP-AQ | $0.34 | [7] |
SMC fixed cost per child per year | $2.13 ($1.00, $4.53) | [7] |
SMC variable cost per protected child per year | $2.31 ($1.67, $3.19) | [7] |
IPTi | ||
IPTi cost per dose SP | $0.16 | [28] S3 |
IPTi fixed costs per child per year | $2.13 ($1.00, $4.53) | [7, 28] |
IPTi variable costs per protected child per year | $1.15 ($0.93, $1.42) | [7, 28] |
RTS,S | ||
RTS,S cost per dose | $5 (assumed) | [29] |
RTS,S fixed cost per child per year | $9.09 ($0.99, $84.20) | [20] |
RTS,S variable cost per fully vaccinated child | $33.31 ($5.66, $197.41) | [20] |
Where cost uncertainty was propagated, costs are shown as median and 95% credible intervals. Costs for treatment of severe and clinical cases were correlated. RTS,S fixed and variable costs were correlated. Treatment distribution and the number of nets distributed increase non-linearly with respect to coverage